Last reviewed · How we verify
NCT03582319
Clinical and Radiographic Evaluation of Biodentine Versus Formocresol
NA trial testing Biodentine in Pulp Disease, Dental in 43 participants. Completed in 22 February 2018.
20 January 2018
Quick facts
| Lead sponsor | Cairo University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 43 |
| Start date | 12 February 2017 |
| Primary completion | 20 January 2018 |
| Estimated completion | 22 February 2018 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Biodentine — full drug profile →
- Formocresol — full drug profile →
Conditions studied
- Pulp Disease, Dental — all drugs for Pulp Disease, Dental →
Sponsor
Cairo University
Who can join
Adults 4 to 6, any sex, with Pulp Disease, Dental. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Aim of the study: To compare Formocresol and Biodentine clinically and radiographically when used for pulpotomy of primary molars Study Design : A randomized control clinical trial (split mouth and double blind) was conducted on 43 (4-6 years-old) children with decayed vital mandibular primary molars which were treated by pulpotomy using both medicaments . All treated teeth were followed for one year (at 3, 6, 9 and 12 months clinically and at 6 and 9 radiographically).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03582319
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Biodentine
Trials testing the same drug.
- NCT06683833 — Comparison Between Egyptian MTA, Biodentine Versus Calcium Hydroxide as Indirect Pulp Capping Materials In Permanent Tee · Phase 4 · recruiting
- NCT07130214 — The Effect of Genetic Polymorphisms on the Success of Vital Pulp Therapy · active not recruiting
- NCT06695208 — Socket Preservation Using Biodentin Versus Xeno Graft for Single Rooted Teeth · Phase 4 · recruiting
- NCT05937100 — New Vital Pulpotomy Medications in Primary Molars · NA · active not recruiting
- NCT06020911 — Indirect Pulp Capping Using Biodentine and Theracal Light-cured in Primary Molars · Phase 4 · completed
Other recruiting trials for Pulp Disease, Dental
Currently open trials in the same condition.
- NCT07130214 — The Effect of Genetic Polymorphisms on the Success of Vital Pulp Therapy · active not recruiting
- NCT06844448 — The Effect of Different Risk Factors on the Success Rate of VPT · recruiting
- NCT06836882 — Effect of Cavity Disinfectants on Post Operative Pain & Success of Partial Caries Removal · NA · recruiting
- NCT05839548 — Articaine Efficacy and Safety for 3 Years Old Children · Phase 3 · active not recruiting
- NCT04793477 — Effectiveness of Rotating System and Single File Reciprocating System in Temporal Molars · NA · recruiting
Other Cairo University trials
Trials by the same sponsor.
- NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
- NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
- NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
- NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
- NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03582319 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cairo University
- Last refreshed: 11 July 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03582319.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing